Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group
N Seersholm, M Wencker, N Banik, K Viskum, A Dirksen, A Kok-Jensen, N Konietzko
European Respiratory Journal 1997 10: 2260-2263; DOI: 10.1183/09031936.97.10102260